Multidisciplinary patient education in groups increases knowledge on osteoporosis: A randomized controlled trial
- 1 June 2008
- journal article
- research article
- Published by SAGE Publications in Scandinavian Journal of Public Health
- Vol. 36 (4), 346-352
- https://doi.org/10.1177/1403494808089558
Abstract
Introduction: Specific pharmacological treatment reduces the incidence of fractures significantly in patients with osteoporosis. Unfortunately, compliance with such therapy is low in clinical practice and is inversely related to educational level. We hypothesized that patients' knowledge of osteoporosis may be increased by a group-based multidisciplinary education programme. Methods: Three hundred patients, aged 45—81 years, recently diagnosed with osteoporosis and started on specific treatment, were randomized to either the "school'' or "control'' group. Teaching was performed by nurses, physiotherapists, dieticians, and doctors, and designed to increase the patient's empowerment. The patient's knowledge of osteoporosis was tested at study entry and at 3 months using a validated questionnaire. Results: At study entry, no differences in age or score (22 (18—24) (median (25—75 percentiles)) vs. 22 (18—24)) were seen between the school and control groups. The change in knowledge during the study, however, differed significantly between the two groups (pKeywords
This publication has 23 references indexed in Scilit:
- Drug Insight: bisphosphonates for postmenopausal osteoporosisNature Clinical Practice Endocrinology & Metabolism, 2006
- Tailored group exercise (Falls Management Exercise — FaME) reduces falls in community-dwelling older frequent fallers (an RCT)Age and Ageing, 2005
- Effect of Dosing Frequency on Bisphosphonate Medication Adherence in a Large Longitudinal Cohort of WomenMayo Clinic Proceedings, 2005
- Group Treatment Improves Trunk Strength and Psychological Status in Older Women with Vertebral Fractures: Results of a Randomized, Clinical TrialJournal of the American Geriatrics Society, 2004
- Compliance with drug therapies for the treatment and prevention of osteoporosisMaturitas, 2004
- Strontium ranelate: a new paradigm in the treatment of osteoporosisExpert Opinion on Investigational Drugs, 2004
- Fracture risk associated with smoking: a meta‐analysisJournal of Internal Medicine, 2003
- Effect of Parathyroid Hormone (1-34) on Fractures and Bone Mineral Density in Postmenopausal Women with OsteoporosisNew England Journal of Medicine, 2001
- Physical Activity, Falls, and Fractures Among Older Adults: A Review of the Epidemiologic EvidenceJournal of the American Geriatrics Society, 2000
- Reduction of Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis Treated With RaloxifeneResults From a 3-Year Randomized Clinical TrialJAMA, 1999